1. Home
  2. LUNG vs HRTX Comparison

LUNG vs HRTX Comparison

Compare LUNG & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • HRTX
  • Stock Information
  • Founded
  • LUNG 1995
  • HRTX 1983
  • Country
  • LUNG United States
  • HRTX United States
  • Employees
  • LUNG N/A
  • HRTX N/A
  • Industry
  • LUNG Industrial Specialties
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LUNG Health Care
  • HRTX Health Care
  • Exchange
  • LUNG Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • LUNG 296.1M
  • HRTX 270.7M
  • IPO Year
  • LUNG 2020
  • HRTX 1987
  • Fundamental
  • Price
  • LUNG $7.52
  • HRTX $2.32
  • Analyst Decision
  • LUNG Strong Buy
  • HRTX Strong Buy
  • Analyst Count
  • LUNG 7
  • HRTX 3
  • Target Price
  • LUNG $12.64
  • HRTX $5.67
  • AVG Volume (30 Days)
  • LUNG 485.0K
  • HRTX 2.6M
  • Earning Date
  • LUNG 04-30-2025
  • HRTX 05-06-2025
  • Dividend Yield
  • LUNG N/A
  • HRTX N/A
  • EPS Growth
  • LUNG N/A
  • HRTX N/A
  • EPS
  • LUNG N/A
  • HRTX N/A
  • Revenue
  • LUNG $83,789,000.00
  • HRTX $144,285,000.00
  • Revenue This Year
  • LUNG $17.96
  • HRTX $11.81
  • Revenue Next Year
  • LUNG $18.35
  • HRTX $15.79
  • P/E Ratio
  • LUNG N/A
  • HRTX N/A
  • Revenue Growth
  • LUNG 22.01
  • HRTX 13.57
  • 52 Week Low
  • LUNG $5.46
  • HRTX $1.04
  • 52 Week High
  • LUNG $10.01
  • HRTX $3.93
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 50.11
  • HRTX 59.27
  • Support Level
  • LUNG $6.97
  • HRTX $2.25
  • Resistance Level
  • LUNG $7.65
  • HRTX $2.45
  • Average True Range (ATR)
  • LUNG 0.67
  • HRTX 0.24
  • MACD
  • LUNG -0.18
  • HRTX 0.01
  • Stochastic Oscillator
  • LUNG 23.40
  • HRTX 65.05

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: